Clinical Trial Update: Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia [Phase 4]

View source ↗

Summary

Phase 4 trial update on Galeo® for postprandial distress syndrome subtype in functional dyspepsia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Functional Dyspepsia

Drugs mentioned

• Galeo®

Snippet

Sponsor: Pusan National University Yangsan Hospital | Conditions: Dyspepsia | Phase 4 | Status: COMPLETED